Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
13.9%
% of BMED's 119 holdings also in PBE
53.6%
% of PBE's 28 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.1% | 5.0% | 3.1% |
|
SAREPTA THERAPEUTICS INC | 2.1% | 3.0% | 2.1% |
|
BIO-TECHNE CORPORATION | 2.1% | 2.7% | 2.1% |
|
NEUROCRINE BIOSCIENCES INC | 1.9% | 3.0% | 1.9% |
|
NATERA INC | 1.8% | 5.4% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to PBE
|
INTUITIVE SURGICAL INC | 5.1% |
|
BOSTON SCIENTIFIC CORP | 4.8% |
 |
ARGENX SE ADR | 3.6% |
 |
ROCHE HOLDING AG-BR | 2.8% |
|
LONZA GROUP AG-REG | 2.6% |
|
UCB SA | 2.5% |
|
ABBOTT LABORATORIES | 2.3% |
|
REPLIGEN CORP | 2.0% |
|
WATERS CORP | 2.0% |
|
DANAHER CORP | 1.8% |
BMED Underweight Relative to PBE
|
INCYTE CORP | -4.8% |
|
REGENERON PHARMACEUTICALS | -4.7% |
|
UNITED THERAPEUTICS CORP | -4.1% |
|
ILLUMINA INC | -4.1% |
|
BIOGEN IDEC INC | -3.9% |
|
NATERA INC | -3.6% |
|
AMGEN INC | -3.4% |
|
ROYALTY PHARMA PLC CLASS A | -3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.9% |